U.S. stocks on the move: Hecla Mining, XPO, Lipocine
SPY•Silver miners fell as metal prices edged lower on a strong U.S. dollar; XPO was upgraded to buy by Citi, and Lipocine surged after Canada approved its testosterone replacement therapy.
1. Three stocks in focus
Silver miners, including Hecla Mining, fell as metal prices edged lower on a strong U.S. dollar. Citi upgraded XPO to buy, citing share gains and pricing strength. Lipocine surged after Canada approved its testosterone replacement therapy.
2. Market backdrop
Wall Street’s main indexes were set for a lower open as Treasury yields and oil prices rose, while investors awaited minutes from the Federal Reserve’s September meeting.
